Anek Prayog Profile
Key Indicators
- Authorised Capital ₹ 6.00 M
- Paid Up Capital ₹ 6.00 M
- Company Age 45 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 17.48%
- Profit Growth -34.37%
- Ebitda 22.14%
- Net Worth 18.36%
- Total Assets 22.99%
About Anek Prayog
Anek Prayog Private Limited (APPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 23 May 1979 and has a history of 45 years and eight months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.00 M and a paid-up capital of Rs 6.00 M, as per Ministry of Corporate Affairs (MCA) records.
Vivekanand Palkar, Sukhada Palkar, and Sonia Palkar serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U73100MH1979PTC021320
-
Company No.
021320
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
23 May 1979
-
Date of AGM
19 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Anek Prayog?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vivekanand Palkar
|
Director | 31-Mar-2001 | Current |
|
Sukhada Palkar
|
Director | 20-Nov-1996 | Current |
|
Sonia Palkar
|
Director | 23-Sep-2002 | Current |
Financial Performance of Anek Prayog.
Anek Prayog Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 17.48% increase. The company also saw a substantial fall in profitability, with a 34.37% decrease in profit. The company's net worth Soared by an impressive increase of 18.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Anek Prayog?
Unlock access to Anek Prayog's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Nivedita Chemicals Private LimitedVivekanand Palkar, Sukhada Palkar and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Anek Prayog?
Anek Prayog has a workforce of 68 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Anek Prayog, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anek Prayog's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.